Get started
Author

Raquel Martin-Domenech

Observed names: Martín Domenech, Raquel, R. Martin-Domenech, R. Martín-Domenech, R. Martín-Doménech, Raquel Martín-Domenech, Raquel Martín-Doménech
OpenAlex ID: A5031486191
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
2018 · On behalf of the BIOBADASER Study Group, Maria V. Hernandez, et al. · Rheumatology International · 37
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
2021 · Carlos Sánchez-Piedra, Diana Sueiro-Delgado, et al. · Scientific Reports · 35
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
2021 · Manuel Pombo-Suarez, Carlos Sanchez-Piedra, et al. · Clinical Rheumatology · 15
Use of benzodiazepines and antidepressants in patients who attend a Rheumatology clinic
2021 · Antonio Álvarez-Cienfuegos, María Paz Martínez-Vidal, et al. · Revista Colombiana de Reumatología (English Edition) · 5
Sat0158 Factors Associated to Persistence of Treatment With Golimumab in the Biobadaser Registry, With up to 6 Years of Follow-up
2019 · Manuel Pombo, Carlos Sánchez-Piedra, et al. · Annals of the Rheumatic Diseases · 3
PDF
OP0140-HPR The Role of a Nurse-Clinic in the Assessment and Prevention of Cardio-Vascular Risk
2015 · N. Martínez Alberola, F. Sivera, et al. · Annals of the Rheumatic Diseases · 3
ABS0131 GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE STUDY ON DRUG RETENTION AND SAFETY IN BIOLOGIC AND TARGETED SYNTHETIC DMARDs
2025 · B. Varas de Dios, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
Pos1281 Implementation of an Electronic Patient-reported Outcome Measures System for Remote Monitoring in Biobadaser: a Multicenter Registry of Advanced Therapies in Rheumatology
2025 · I. Castrejon, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
Pos0281 Safety of Biosimilars Therapies for the Treatment of Juvenile Idiopathic Arthritis: Results From the Spanish Registry of Adverse Events With Biologic Therapies (biobadaser)
2023 · J.J. Bethencourt Baute, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
PDF
Ab1423 Use of Biosimilar Therapies in Adult Patients Diagnosed With Juvenile Idiopathic Arthritis: Results From the Spanish Registry of Adverse Events With Biologic Therapies (biobadaser)
2023 · J.J. Bethencourt Baute, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
PDF
Pos1081 Osteoporosis and Insufficiency Risk Factors in Psoriatic Arthritis
2021 · M.P. Martínez-Vidal, V. Jovani, et al. · Annals of the Rheumatic Diseases
Use of benzodiazepines and antidepressants in patients who attend a Rheumatology clinic
2021 · Antonio Álvarez-Cienfuegos, María Paz Martínez-Vidal, et al. · Revista Colombiana de Reumatología
Thu0464 Use of Benzodiazepines and Antidepressants in Patients Who Attend a Rheumatology Clinic
2020 · M.P. Martínez-Vidal, A. Alvarez de Cienfuegos, et al. · Annals of the Rheumatic Diseases
PDF
SAT0651 Carotid ultrasound in patients with arthritis: ¿in which patients does it re-stratify cv risk?
2018 · F. Sivera, N. Martinez-Alberola, et al. · Annals of the Rheumatic Diseases
PDF
THU0154 A program for screening and treatment of cardiovascular risk factors in patients with chronic arthritis: 2-year results
2018 · G. Albert-Espi, N. Martinez-Alberola, et al. · Annals of the Rheumatic Diseases
PDF
SAT0576 Score Understimates the Real Cardiovascular Risk in Psoriatic Arthritis
2015 · M. Martínez-Vidal, F. Sivera, et al. · Annals of the Rheumatic Diseases
Works count: 17
Citation count: 98
H-index: 4
I10-index: 3
Year
Topic
Type